The tumor microenvironment and metastatic disease
- 10 June 2008
- journal article
- review article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 26 (1) , 19-34
- https://doi.org/10.1007/s10585-008-9182-2
Abstract
The microenvironment of solid tumors is a heterogeneous, complex milieu for tumor growth and survival that includes features such as acidic pH, low nutrient levels, elevated interstitial fluid pressure (IFP) and chronic and fluctuating levels of oxygenation that relate to the abnormal vascular network that exists in tumors. The metastatic potential of tumor cells is believed to be regulated by interactions between the tumor cells and their extracellular environment (extracellular matrix (ECM)). These interactions can be modified by the accumulation of genetic changes and by the transient alterations in gene expression induced by the local tumor microenvironment. Clinical and experimental evidence suggests that altered gene expression in response to the hypoxic microenvironment is a contributing factor to increased metastatic efficiency. A number of genes that have been implicated in the metastatic process, involving angiogenesis, intra/extravasation, survival and growth, have been found to be hypoxia-responsive. The various metastatic determinants, genetic and epigenetic, somatic and inherited may serve as precedents for the future identification of more genes that are involved in metastasis. Much research has focused on genetic and molecular properties of the tumor cells themselves. In the present review we discuss the epigenetic and physiological regulation of metastasis and emphasize the need for further studies on the interactions between the pathophysiologic tumor microenvironment and the tumor extracellular matrix.Keywords
This publication has 210 references indexed in Scilit:
- Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinomaProceedings of the National Academy of Sciences, 2007
- Treatment with imatinib improves drug delivery and efficacy in NSCLC xenograftsBritish Journal of Cancer, 2007
- Metastasis and stem cell pathwaysCancer and Metastasis Reviews, 2007
- Hypoxia-Inducible Factors, Stem Cells, and CancerCell, 2007
- Hypoxia, gene expression, and metastasisCancer and Metastasis Reviews, 2007
- Hypoxia-inducible factors: central regulators of the tumor phenotypeCurrent Opinion in Genetics & Development, 2007
- Inhibition of carcinoma cell‐derived VEGF reduces inflammatory characteristics in xenograft carcinomaInternational Journal of Cancer, 2006
- Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4British Journal of Cancer, 2006
- Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activationOncogene, 2005
- The Hallmarks of CancerCell, 2000